Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

7.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.5K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Protein-protein Interfaces02:04

Protein-protein Interfaces

13.8K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
13.8K
Principles of Drug Action01:24

Principles of Drug Action

6.7K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.7K
Patch Clamp01:18

Patch Clamp

5.8K
Many fundamental cell functions such as muscle contraction and nerve transmission rely on the electrical signals produced by the movement of positively and negatively charged ions across the cell membrane. One competent method to record current flowing across the whole cell or single ion channel is the patch-clamp technique.
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
5.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PSFF-PTM: A Coarse-Grained Force-Field Parameter Patch for Modeling Post-Translational Modification Effects on Biomolecular Condensates.

Journal of chemical theory and computation·2026
Same author

Development of a Rapid and Sensitive AlphaLISA-Based Assay for Lassa Virus Glycoprotein Detection.

Pathogens (Basel, Switzerland)·2026
Same author

MGTbind: a comprehensive database of molecular glue ternary interactome.

Nucleic acids research·2025
Same author

Modeling protein-ligand interactions for drug discovery in the era of deep learning.

Chemical Society reviews·2025
Same author

DiffPepDock: Efficient protein-peptide docking and binder screening via SE(3)-equivariant diffusion.

Protein science : a publication of the Protein Society·2025
Same author

GeoEvoBuilder: A deep learning framework for efficient functional and thermostable protein design.

Proceedings of the National Academy of Sciences of the United States of America·2025

Related Experiment Video

Updated: Sep 20, 2025

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.0K

Computer-Aided Drug Discovery for Undruggable Targets.

Qi Sun1,2, Hanping Wang1, Juan Xie3

  • 1BNLMS, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, China.

Chemical Reviews
|May 27, 2025
PubMed
Summary

Computational and AI strategies are revolutionizing drug design for challenging "undruggable" targets. These advanced methods offer new therapeutic avenues for diseases previously considered untreatable.

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.1K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

546

Related Experiment Videos

Last Updated: Sep 20, 2025

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.0K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.1K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

546

Area of Science:

  • Computational chemistry and drug discovery
  • Artificial intelligence in medicine
  • Biochemistry and structural biology

Background:

  • Undruggable targets pose significant therapeutic challenges due to unique structural and functional characteristics.
  • Conventional drug design methods struggle with targets lacking well-defined pockets or involving dynamic interactions.
  • Protein-protein interactions and intrinsically disordered proteins represent key undruggable target classes.

Purpose of the Study:

  • To review recent computational and AI-driven advances in designing drugs against undruggable targets.
  • To highlight successful case studies and emerging strategies in this field.
  • To discuss future directions and remaining challenges in expanding the druggable proteome.

Main Methods:

  • Review of computational simulation and artificial intelligence methodologies.
  • Analysis of AI applications in structure prediction, virtual screening, and de novo ligand design.
  • Integration of computational approaches with experimental validation techniques.

Main Results:

  • Computational and AI methods are enabling novel strategies for targeting previously undruggable proteins.
  • Successful case studies demonstrate the efficacy of these advanced approaches.
  • AI significantly enhances protein-ligand complex prediction and ligand generation for challenging targets.

Conclusions:

  • Advanced computational and AI tools are crucial for overcoming limitations in drug design for undruggable targets.
  • Integrating computational and experimental methods promises further breakthroughs.
  • These advancements expand therapeutic opportunities for intractable diseases by broadening the druggable space.